Diagnostic and Therapeutic Challenges of Chronic Portal Vein Thrombosis Secondary to Myeloproliferative Neoplasm in Sub-Saharan Region: A Series of Cases and Literature Review
Abdu Mohammed,Abate Bane Shewaye,Fozia Abdela,Zebeaman Tibebu Gorfu,Ahmed Adem
DOI: https://doi.org/10.2147/IMCRJ.S385219
2023-01-05
International Medical Case Reports Journal
Abstract:Abdu Mohammed, 1 Abate Bane Shewaye, 1, 2 Fozia Abdela, 1, 2 Zebeaman Tibebu Gorfu, 1 Ahmed Adem 1, 2 1 Department of Internal Medicine, Adera Medical Center, Addis Ababa, Ethiopia; 2 Department of internal Medicine, Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia Correspondence: Abdu Mohammed, Tel +251-913-103-656, Email Myeloproliferative neoplasms (MPN) are the commonest causes of non-cirrhotic abdominal vein thrombosis. MPN was observed in 30− 40% with Budd Chiari Syndrome (BCS) and portal vein thrombosis (PVT), whereas this is the cause in only a minority of other types of venous thrombosis. Herein, we report 10 cases of chronic PVT secondary to Janus Kinase 2 gene (JAk 2) positive myeloproliferative neoplasm (MPN). The median age was 35 years with M:F 1:1. Portal hypertension was present at presentation in all of them. Nine patients have esophageal varices, of which 6 have bleeding at presentation. Classical MPN phenotype on complete blood count (CBC) was not present in 6 of them. Management of patients with anticoagulation was difficult with 4 patients experiencing bleeding during anticoagulation, and bleeding occurring despite the target international normalized ratio (INR) in 2 of them. Portal hypertension leading to hypersplenism and hemodilution may mask erythrocytosis and thrombocytosis, which are the main criteria used to diagnose MPN. The resulting absence of a typical MPN phenotype in routine laboratory studies alongside accessibility issues, and the need for a multidisciplinary treatment approach imparts a diagnostic as well as a therapeutic challenge for chronic PVT associated with Jak 2 positive MPN in sub-Saharan patients. Keywords: portal cavernoma, cholangiopathy, Jak 2 mutation, MPN, Ethiopia, sub-Sahara Cavernous transformation of the portal vein or portal cavernoma is the formation of venous channels within or around a previously thrombosed portal vein. 1 It occurs 6–20 days after the thrombotic event, even after the development of partial recanalization of the thrombus. 2 Chronic Thrombosis of Portal Vein (CTPV) is the most common cause of extrahepatic Portal Vein Obstruction (EHPVO) in adults with underlying prothrombotic conditions. The most frequent cause are BCR-ABL-1 negative MPNs. Among these, the pooled prevalence of thrombosis is highest for Polycythemia Vera (PV), at 28.6%, followed by Essential Thrombocythemia (ET) at 20.7%, and lowest for Primary Myelofibrosis (PMF) at 9.5%. 3 Main complications of chronic EHPVO are portal hypertension and portal cavernoma cholangiopathy. 4 The primary diagnostic modality of choice is Doppler ultrasound followed by computed tomography (CT) scan for confirmation and further evaluation. Management of patients is aimed at preventing complications, as better control of hemorrhagic and thrombotic complications substantially improves life span and clinical outcomes. 5,6 The asymptomatic presentation of patients alongside the lack of access to specialist care and superior diagnostic modalities like the JAK2 mutation test renders a challenge for diagnosis in the sub-Saharan region where most patients already present with complications to point of care. Furthermore, the proper therapy could not be instituted straightaway as correct management necessitates a follow-up by a multidisciplinary team and a series of laboratory investigations. Consequently, management is not optimized in most cases. This case series is a retrospective analysis of CTPV with Jak 2 Positive MPN patients having follow-up at Adera Medical center, Addis Ababa, Ethiopia. All patients with positive JAK2V617F mutation alongside CT or ultrasound diagnosis of chronic portal vein thrombosis were enrolled into this case series. Complete sociodemographic, clinical, biochemical, pathological, and endoscopic values were collected from patient charts. A 51-year-old male presented to our outpatient department (OPD) with a three-year history of progressive abdominal distention with recent worsening. He also complains of intermittent abdominal pain and tenesmus with associated bright red per rectal bleeding. For these complaints, he was put on diuretics therapy by primary care physicians. On physical examination, he had a mildly pale conjunctiva. Abdominal examination revealed a protuberant abdomen with shifting dullness and a reducible umbilical hernia along with a ballotable spleen. Bilateral pedal and pretibial edema were also appreciated. Investigations revealed; leukocytosis (White Blood Cell count (WBC) of 21,900/l), mild anemia (Hemoglobin (Hgb) – 11.4 gm/dl), and Platelet (PLT) – 416,000/l), moderate hypoalbuminemia (Albumin- 2.1gm/dl). Ultrasound examination of the abdomen identified splenomegaly with asc -Abstract Truncated-